Todd Barry

3.3k total citations
45 papers, 2.3k citations indexed

About

Todd Barry is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Todd Barry has authored 45 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cancer Research, 12 papers in Pathology and Forensic Medicine and 12 papers in Oncology. Recurrent topics in Todd Barry's work include Breast Cancer Treatment Studies (10 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Ovarian cancer diagnosis and treatment (7 papers). Todd Barry is often cited by papers focused on Breast Cancer Treatment Studies (10 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Ovarian cancer diagnosis and treatment (7 papers). Todd Barry collaborates with scholars based in United States, Sweden and Canada. Todd Barry's co-authors include Allen M. Gown, Brigitte M. Ronnett, Russell Vang, Darren Wheeler, Hadi Yaziji, Jeffrey D. Seidman, Anna Yemelyanova, Barton F. Haynes, Harry C. Hwang and Torsten O. Nielsen and has published in prestigious journals such as Nature Medicine, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Todd Barry

43 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Todd Barry United States 25 747 568 492 482 430 45 2.3k
Christine Galant Belgium 26 518 0.7× 346 0.6× 365 0.7× 333 0.7× 262 0.6× 129 2.2k
Stuart D. Flynn United States 28 625 0.8× 414 0.7× 405 0.8× 248 0.5× 410 1.0× 60 2.3k
Norihiro Teramoto Japan 25 940 1.3× 433 0.8× 160 0.3× 582 1.2× 367 0.9× 125 2.2k
Pekka Klemi Finland 30 1.1k 1.5× 541 1.0× 289 0.6× 426 0.9× 705 1.6× 99 3.1k
Preetha Ramalingam United States 29 757 1.0× 321 0.6× 529 1.1× 328 0.7× 552 1.3× 94 2.2k
F. A. Tavassoli United States 24 615 0.8× 649 1.1× 380 0.8× 517 1.1× 690 1.6× 43 2.3k
Mamatha Chivukula United States 23 532 0.7× 453 0.8× 207 0.4× 216 0.4× 292 0.7× 53 1.7k
Kyle Molberg United States 26 716 1.0× 461 0.8× 203 0.4× 319 0.7× 529 1.2× 66 1.9k
Friedrich Kommoss Germany 29 684 0.9× 239 0.4× 934 1.9× 293 0.6× 448 1.0× 75 2.5k
Joan Cangiarella United States 31 729 1.0× 1.3k 2.3× 188 0.4× 611 1.3× 932 2.2× 135 3.3k

Countries citing papers authored by Todd Barry

Since Specialization
Citations

This map shows the geographic impact of Todd Barry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd Barry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd Barry more than expected).

Fields of papers citing papers by Todd Barry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Todd Barry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd Barry. The network helps show where Todd Barry may publish in the future.

Co-authorship network of co-authors of Todd Barry

This figure shows the co-authorship network connecting the top 25 collaborators of Todd Barry. A scholar is included among the top collaborators of Todd Barry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Todd Barry. Todd Barry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martin, David S., et al.. (2022). Molecular confirmation of primary monophasic synovial sarcoma of the mandible: diagnosis and management. British Journal of Oral and Maxillofacial Surgery. 60(7). 994–996. 2 indexed citations
2.
Weinmann, Sheila, Michael C. Leo, Melanie Francisco, et al.. (2020). Validation of a Ductal Carcinoma In Situ Biomarker Profile for Risk of Recurrence after Breast-Conserving Surgery with and without Radiotherapy. Clinical Cancer Research. 26(15). 4054–4063. 34 indexed citations
3.
Bremer, Troy, Pat W. Whitworth, Rakesh Patel, et al.. (2018). A Biological Signature for Breast Ductal Carcinoma In Situ to Predict Radiotherapy Benefit and Assess Recurrence Risk. Clinical Cancer Research. 24(23). 5895–5901. 71 indexed citations
4.
Linke, Steven P., Troy Bremer, Pat W. Whitworth, et al.. (2015). Validation of a multi-marker test that predicts recurrence in patients diagnosed with ductal carcinoma in situ (DCIS) treated with breast-conserving surgery (BCS). Cancer Research. 75(9). 1 indexed citations
5.
Gunn, Shelly, Jae‐Weon Kim, Rashmi R. Shah, et al.. (2013). Molecular cytogenetics as a clinical test for prognostic and predictive biomarkers in newly diagnosed ovarian cancer. Journal of Ovarian Research. 6(1). 2–2. 9 indexed citations
6.
Barry, Todd, et al.. (2011). Histopathological findings in 29 lymph node biopsies with increased IgG4 plasma cells. Modern Pathology. 25(3). 480–491. 37 indexed citations
7.
Yaziji, Hadi, Clive R. Taylor, Neal S. Goldstein, et al.. (2008). Consensus Recommendations on Estrogen Receptor Testing in Breast Cancer By Immunohistochemistry. Applied immunohistochemistry & molecular morphology. 16(6). 513–520. 85 indexed citations
8.
Farinola, Maryam A., Allen M. Gown, Kara Judson, et al.. (2007). Estrogen Receptor α and Progesterone Receptor Expression in Ovarian Adult Granulosa Cell Tumors and Sertoli-Leydig Cell Tumors. International Journal of Gynecological Pathology. 26(4). 375–382. 44 indexed citations
9.
Vang, Russell, Allen M. Gown, Maryam A. Farinola, et al.. (2007). p16 Expression in Primary Ovarian Mucinous and Endometrioid Tumors and Metastatic Adenocarcinomas in the Ovary. The American Journal of Surgical Pathology. 31(5). 653–663. 57 indexed citations
11.
Yaziji, Hadi & Todd Barry. (2006). Diagnostic Immunohistochemistry: What can Go Wrong?. Advances in Anatomic Pathology. 13(5). 238–246. 61 indexed citations
12.
Collins, Laura C., et al.. (2006). Intracystic Papillary Carcinomas of the Breast: A Reevaluation Using a Panel of Myoepithelial Cell Markers. The American Journal of Surgical Pathology. 30(8). 1002–1007. 124 indexed citations
15.
Vang, Russell, Allen M. Gown, Todd Barry, Darren Wheeler, & Brigitte M. Ronnett. (2005). Ovarian Atypical Proliferative (Borderline) Mucinous Tumors: Gastrointestinal and Seromucinous (Endocervical-Like) Types are Immunophenotypically Distinctive. International Journal of Gynecological Pathology. 25(1). 83–89. 63 indexed citations
16.
Ng, Tony, Allen M. Gown, Todd Barry, et al.. (2004). Nuclear beta-catenin in mesenchymal tumors. Modern Pathology. 18(1). 68–74. 214 indexed citations
18.
O’Malley, Dennis P., Kent E. Opheim, Todd Barry, et al.. (2001). Chromosomal changes in a dedifferentiated chondrosarcoma. Cancer Genetics and Cytogenetics. 124(2). 105–111. 16 indexed citations
19.
Chen, Xueni, Giuseppe Scala, Ileana Quinto, et al.. (2001). Protection of rhesus macaques against disease progression from pathogenic SHIV-89.6PD by vaccination with phage-displayed HIV-1 epitopes. Nature Medicine. 7(11). 1225–1231. 64 indexed citations
20.
Barry, Todd & Barton F. Haynes. (1992). In vivo models of human lymphopoiesis and autoimmunity in severe combined immune deficient mice. Journal of Clinical Immunology. 12(5). 311–324. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026